| __timestamp | Sarepta Therapeutics, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 94103000 | 520990000000 |
| Thursday, January 1, 2015 | 146194000 | 535405000000 |
| Friday, January 1, 2016 | 130000 | 558755000000 |
| Sunday, January 1, 2017 | 7353000 | 495921000000 |
| Monday, January 1, 2018 | 34193000 | 659690000000 |
| Tuesday, January 1, 2019 | 56586000 | 1089764000000 |
| Wednesday, January 1, 2020 | 63382000 | 994308000000 |
| Friday, January 1, 2021 | 97049000 | 1106846000000 |
| Saturday, January 1, 2022 | 139989000 | 1244072000000 |
| Sunday, January 1, 2023 | 150343000 | 1431505000000 |
| Monday, January 1, 2024 | 1431505000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This analysis delves into the cost of revenue trends for Takeda Pharmaceutical Company Limited and Sarepta Therapeutics, Inc. from 2014 to 2023. Takeda, a global leader, consistently shows a robust cost of revenue, peaking at approximately 1.43 trillion in 2023, reflecting a 175% increase since 2014. In contrast, Sarepta, a pioneering biotech firm, exhibits a more volatile pattern, with costs rising from 94 million in 2014 to 150 million in 2023, marking a 60% increase. Notably, 2016 was an anomaly for Sarepta, with costs plummeting to a mere 130,000, highlighting potential strategic shifts. This comparative insight underscores the diverse financial strategies employed by these industry giants, offering a window into their operational efficiencies and market positioning.
Cost of Revenue Comparison: Pfizer Inc. vs Takeda Pharmaceutical Company Limited
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.
Cost of Revenue Comparison: Takeda Pharmaceutical Company Limited vs CRISPR Therapeutics AG
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Amneal Pharmaceuticals, Inc.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Intra-Cellular Therapies, Inc. vs Sarepta Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and Jazz Pharmaceuticals plc
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and Lantheus Holdings, Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Corcept Therapeutics Incorporated's Expenses
Comparing Cost of Revenue Efficiency: Sarepta Therapeutics, Inc. vs Alkermes plc
Sarepta Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Efficiency in Cost of Revenue Explored